Merieux Equity Partners: Funding, Team & Investors

Mérieux Equity Partners is a specialized European investment firm focused on the healthcare sector. It deploys capital and tailored support to foster the development and growth of high-potential enterprises. The firm operates through distinct innovation (venture capital) and buyout strategies, targeting disruptive technologies and profitable companies across various healthcare sub-segments.

The firm commenced its investment activities in 2009, rooted in the Mérieux family's extensive history and industrial expertise within healthcare. This deep sector insight formed the foundational premise for establishing a dedicated investment vehicle. It leverages its connection to Institut Mérieux, benefiting from a robust network and long-term strategic vision.

Mérieux Equity Partners primarily serves management teams and entrepreneurs across the healthcare landscape, partnering from early-stage development through to large-scale deployment. Its vision is to act as an active, supportive shareholder, integrating responsible investment practices to build lasting value and drive strategic growth, ultimately advancing the healthcare industry.

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Apr 1, 2025	DeepUll	$57.0M Series C	Columbus Venture Partners, Merieux Equity Partners, Panakes Partners	Asabys Partners, Vsquared Ventures, Aliath Bioventures, Axis Participaciones Empresariales, CDTI Innvierte, Kurma Partners, UI Investissement, WE Venture Capital
Nov 1, 2023	Amyl Therapeutics	$6.0M Series A	Gaëtan Servais	Earlybird Venture Capital, Noshaq, Evren Ucok
May 1, 2023	TISSIUM	$54.0M Series D	—	Abingworth, Soffinova Partners, Cathay Capital, Credit Mutuel Innovation, Isalt
Aug 25, 2022	AstriVax	$29.9M Seed	Caroline Goddeeris, Shelley Margetson	Ackermans & VAN Haaren, BNP Paribas Fortis Private Equity, Flanders Future Tech Fund, KU Leuven, Thuja Capital
Jun 1, 2020	TARA Biosystems	$10.0M Series A	—	OMX Ventures, Alexandria Venture Investments, DEFTA Partners, LifeForce Capital, NEW York Ventures, Partnership Fund For NEW York City, Tachyon Ventures, Trancos Ventures
Apr 1, 2019	Inscripta	$20.0M Series C	—	Accel, AME Cloud Ventures, ARCH Venture Partners, Gideon YU, Hardware Club, Ligature, Morado Venture Partners, NanoDimension, Paladin Capital Group, Prefix Capital, Thomvest Ventures, Venrock, Westlake Village BioPartners, Farzad Nazem, Vishal Makhijani, Foresite Capital, Malaysian Life Sciences Capital Fund, NanoDimension
Jan 10, 2017	Ivantis	$25.0M Series C	Peter Kolchinsky	—
Sep 7, 2016	Proclara Biosciences	$47.0M Series E	Merieux Equity Partners	—
Sep 9, 2015	Biom'Up	$34.9M Series C	—	Laurent Higueret, Euroainvest, Karl Nagler, Innobio, L'améliane, Casper Breum, OTC AM, Sham, Sofimac, Viveris Management
May 11, 2014	ImaginAb	$21.0M Series B	Merieux Equity Partners	Cycad Group, Nextech Invest, Novartis
Oct 25, 2012	Biom'Up	$8.8M Other Equity	—	Apicap, Aquasourca, Emmeline Ventures, InnoBio Fund, Sham, Sofimac Partners, Viveris Management
Mar 27, 2012	ImaginAb	$12.5M Series A	Campbell Murray	Cycad Group, Momentum Biosciences, Nextech Invest
Nov 1, 2010	SuperSonic Imagine	$45.0M Series C	Merieux Equity Partners	Andera Partners

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Apr 1, 2025	DeepUll	$57.0M Series C	Columbus Venture Partners, Merieux Equity Partners, Panakes Partners	Asabys Partners, Vsquared Ventures, Aliath Bioventures, Axis Participaciones Empresariales, CDTI Innvierte, Kurma Partners, UI Investissement, WE Venture Capital
Nov 1, 2023	Amyl Therapeutics	$6.0M Series A	Gaëtan Servais	Earlybird Venture Capital, Noshaq, Evren Ucok
May 1, 2023	TISSIUM	$54.0M Series D	—	Abingworth, Soffinova Partners, Cathay Capital, Credit Mutuel Innovation, Isalt
Aug 25, 2022	AstriVax	$29.9M Seed	Caroline Goddeeris, Shelley Margetson	Ackermans & VAN Haaren, BNP Paribas Fortis Private Equity, Flanders Future Tech Fund, KU Leuven, Thuja Capital
Jun 1, 2020	TARA Biosystems	$10.0M Series A	—	OMX Ventures, Alexandria Venture Investments, DEFTA Partners, LifeForce Capital, NEW York Ventures, Partnership Fund For NEW York City, Tachyon Ventures, Trancos Ventures
Apr 1, 2019	Inscripta	$20.0M Series C	—	Accel, AME Cloud Ventures, ARCH Venture Partners, Gideon YU, Hardware Club, Ligature, Morado Venture Partners, NanoDimension, Paladin Capital Group, Prefix Capital, Thomvest Ventures, Venrock, Westlake Village BioPartners, Farzad Nazem, Vishal Makhijani, Foresite Capital, Malaysian Life Sciences Capital Fund, NanoDimension
Jan 10, 2017	Ivantis	$25.0M Series C	Peter Kolchinsky	—
Sep 7, 2016	Proclara Biosciences	$47.0M Series E	Merieux Equity Partners	—
Sep 9, 2015	Biom'Up	$34.9M Series C	—	Laurent Higueret, Euroainvest, Karl Nagler, Innobio, L'améliane, Casper Breum, OTC AM, Sham, Sofimac, Viveris Management
May 11, 2014	ImaginAb	$21.0M Series B	Merieux Equity Partners	Cycad Group, Nextech Invest, Novartis
Oct 25, 2012	Biom'Up	$8.8M Other Equity	—	Apicap, Aquasourca, Emmeline Ventures, InnoBio Fund, Sham, Sofimac Partners, Viveris Management
Mar 27, 2012	ImaginAb	$12.5M Series A	Campbell Murray	Cycad Group, Momentum Biosciences, Nextech Invest
Nov 1, 2010	SuperSonic Imagine	$45.0M Series C	Merieux Equity Partners	Andera Partners

Merieux Equity Partners

Subscribe, Save or Share

About

Investment Activity

Investments Made

Financial History

Investment Activity

Investments Made